Literature DB >> 7173321

Phencyclidine-like discriminative stimuli of (+)- and (-)-N-allylnormetazocine in rats.

H E Shannon.   

Abstract

The phencyclidine(PCP)-like discriminative stimulus properties of the (+)- and (-)-isomers of the prototypic sigma-receptor agonist N-allylnormetazocine (NANM) were evaluated in rats trained to discriminate between saline and 3.0 mg/kg of PCP. The rats were trained under a FR5 schedule of stimulus-shock termination. Both (+)- and (-)-NANM produced PCP-like stimuli and were approximately one-half and one-sixth, respectively, as potent as PCP. The two isomers were equipotent in decreasing response rates. None of the effects of either (+)- or (-)-NANM were antagonized by naloxone. These results demonstrate that the PCP-like effects of NANM exhibit stereoselectivity but not stereospecificity and are additional evidence that the common actions of PCP and NANM are mediated by sigma-receptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7173321     DOI: 10.1016/0014-2999(82)90207-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  Inhibition of (+)[3H]SKF 10,047 binding to rat brain membranes by FAB fragments from a monoclonal antibody directed against the opioid receptor.

Authors:  C B Tyler; J M Bidlack
Journal:  Neurochem Res       Date:  1988-08       Impact factor: 3.996

2.  Evaluation of the effects of opioid agonists and antagonists under a delayed matching-to-sample procedure in pigeons.

Authors:  M Picker; C A Massie; L A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents.

Authors:  Adam L Halberstadt; Natalia Slepak; James Hyun; Mahalah R Buell; Susan B Powell
Journal:  Psychopharmacology (Berl)       Date:  2016-01-13       Impact factor: 4.530

4.  Comparison of the pharmacologic effects of N-allylnormetazocine and phencyclidine: sensitization, cross-sensitization, and opioid antagonist activity.

Authors:  E T Iwamoto
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 5.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982-1983.

Authors:  I P Stolerman; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice.

Authors:  Adam L Halberstadt; James Hyun; Michael A Ruderman; Susan B Powell
Journal:  Pharmacol Biochem Behav       Date:  2016-05-26       Impact factor: 3.533

7.  Discriminative stimulus properties of (+)-N-allylnormetazocine in the rat: correlations with (+)-N-allylnormetazocine and phencyclidine receptor binding.

Authors:  G F Steinfels; S W Tam; L Cook
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 8.  Ketamine and phencyclidine: the good, the bad and the unexpected.

Authors:  D Lodge; M S Mercier
Journal:  Br J Pharmacol       Date:  2015-07-28       Impact factor: 8.739

9.  Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047).

Authors:  L Singh; E H Wong; A C Kesingland; M D Tricklebank
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

Review 10.  Phencyclidine. Physiological actions, interactions with excitatory amino acids and endogenous ligands.

Authors:  P C Contreras; J B Monahan; T H Lanthorn; L M Pullan; D A DiMaggio; G E Handelmann; N M Gray; T L O'Donohue
Journal:  Mol Neurobiol       Date:  1987       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.